Home » Stocks » ECOR

electroCore, Inc. (ECOR)

Stock Price: $3.05 USD 0.31 (11.31%)
Updated Jan 26, 2021 3:57 PM EST - Market closed
Market Cap 124.55M
Revenue (ttm) 3.24M
Net Income (ttm) -25.69M
Shares Out 44.03M
EPS (ttm) -0.73
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 26
Last Price $3.05
Previous Close $2.74
Change ($) 0.31
Change (%) 11.31%
Day's Open 3.12
Day's Range 2.86 - 3.29
Day's Volume 6,258,737
52-Week Range 0.33 - 3.29

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 5 days ago

ROCKAWAY, N.J., Jan. 21, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Health Improvement Scotland (“HIS”) ...

GlobeNewsWire - 1 week ago

ROCKAWAY, N.J., Jan. 19, 2021 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Centers for Medicare and Medicaid Se...

GlobeNewsWire - 2 weeks ago

Full year 2020 revenue expected at the upper end of previously announced guidance range of $3.3M - $3.5M; greater than 40% growth over full year 2019 revenue of $2.4M

GlobeNewsWire - 1 month ago

ROCKAWAY, N.J., Dec. 21, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into an agreement wit...

GlobeNewsWire - 1 month ago

BASKING RIDGE, N.J., Dec. 07, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that management is scheduled to pres...

Seeking Alpha - 2 months ago

electroCore's (ECOR) CEO Dan Goldberger on Q3 2020 Results - Earnings Call Transcript

Benzinga - 2 months ago

Shares of electroCore (NASDAQ:ECOR) moved higher by 10.83% in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 71.43% over the past year...

Benzinga - 2 months ago

On Thursday, November 12, electroCore (NASDAQ: ECOR) will report its last quarter's earnings. Here is Benzinga's preview of the company's release.

GlobeNewsWire - 2 months ago

Conference Call to be Held at 4:30pm Eastern Time Conference Call to be Held at 4:30pm Eastern Time

GlobeNewsWire - 3 months ago

Third quarter 2020 Revenue expected to exceed $1 million , representing an increase of greater than 35% sequentially and greater than 50% over Q3 2019

GlobeNewsWire - 3 months ago

ITP program providing reimbursement for gammaCore ™ extended to March. 31, 2021 with option for additional three years

GlobeNewsWire - 3 months ago

BASKING RIDGE, N.J., Sept. 30, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the Department of Veterans Aff...

GlobeNewsWire - 4 months ago

Comprehensive telehealth platform to facilitate the efficient procurement of gammaCore Sapphire™ CV (non-invasive vagus nerve stimulator) by known or suspected COVID-19 patients Comprehensive ...

GlobeNewsWire - 4 months ago

BASKING RIDGE, N.J., Sept. 23, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that Dan Goldberger, chief execut...

GlobeNewsWire - 4 months ago

BASKING RIDGE, N.J., Sept. 11, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that management is scheduled to p...

GlobeNewsWire - 4 months ago

BASKING RIDGE, N.J., Aug. 27, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced the publication of a paper, entitl...

GlobeNewsWire - 5 months ago

Reimbursement for gammaCore™ in England Reimbursement for gammaCore™ in England

InvestorPlace - 5 months ago

Rock-solid financial stats and a highly specific medical technology add up to a compelling argument in favor of ECOR stock. The post Make ElectroCore a Core Holding after an Outstanding Q2 app...

Seeking Alpha - 5 months ago

electroCore, Inc's (ECOR) CEO Dan Goldberger on Q2 2020 Results - Earnings Call Transcript

Benzinga - 5 months ago

Shares of electroCore (NASDAQ:ECOR) fell 3.1% in after-market trading after the company reported Q2 results.

GlobeNewsWire - 5 months ago

Received EUA and initiated gammaCore Sapphire CV distribution process for certain known or suspected COVID-19 patients experiencing asthma exacerbations

GlobeNewsWire - 5 months ago

Conference Call to be Held at 4:30pm Eastern Time Conference Call to be Held at 4:30pm Eastern Time

24/7 Wall Street - 5 months ago

Whether it’s all speculation or day trading, it seems there is no end to seeing major gains in small and micro-cap stocks that have positive announcements around anything to do with testing, v...

GlobeNewsWire - 5 months ago

Initial distribution to hospitals and patients expected to begin on July 31st Initial distribution to hospitals and patients expected to begin on July 31st

InvestorPlace - 5 months ago

Bioelectronic medicine's crucial role has come into focus with Covid-19, and a recent FDA approval practically assures ECOR stock's ascent. The post FDA Green Light Makes ElectroCore a Micro-...

GlobeNewsWire - 5 months ago

Paper supports use of nVNS as a front-line therapy for acute and preventative treatment of cluster headache and as an effective option for the treatment of migraine headache Paper supports use...

GlobeNewsWire - 6 months ago

BASKING RIDGE, N.J., July 16, 2020 (GLOBE NEWSWIRE) -- In a release issued under the same headline on July 14, 2020, the company’s cash was incorrectly stated as being as of the end of the f...

InvestorPlace - 6 months ago

ElectroCore (ECOR) news for Monday concerning emergency authorization from the FDA for one of its drugs to treat coronavirus. The post ElectroCore News: Why ECOR Stock Is Skyrocketing 142% Tod...

Market Watch - 6 months ago

Shares of electroCore Inc. ECOR, +142.94% more than doubled (up 155%) on very heavy volume in afternoon trading Monday, after the bioelectronic medicine company said it was issued an emergency...

GlobeNewsWire - 6 months ago

Intended use allows gammaCore Sapphire CV use at home or in a healthcare setting Intended use allows gammaCore Sapphire CV use at home or in a healthcare setting

GlobeNewsWire - 6 months ago

BASKING RIDGE, N.J., July 09, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executi...

Forbes - 6 months ago

As the virus spreads, if you’re looking to bet against the market or hedge, our deep learning algorithms paired with out Artificial Intelligence (“AI”) data has some Top Shorts named for you t...

Other stocks mentioned: BCRX, PDSB, TTPH, CRDF
Forbes - 7 months ago

If you’re looking to hedge some downside, or if you think the market has gone too far to the upside, our deep learning algorithms have used Artificial Intelligence (“AI”) technology to identif...

Other stocks mentioned: GRUB, OCGN, RCL, SAGE
Forbes - 7 months ago

Retail sales surging 18% in May fared well with the markets this morning, but with growing concerns over a Coronavirus resurgence, it's clear that volatility is just around the corner. We've u...

Other stocks mentioned: ARCB, FLNT, GRUB, NAVB
Forbes - 7 months ago

With the S&P 500, Nasdaq, and Dow going positive today, we link the markets are overextended. Our deep learning and AI has identified several Top Shorts today for you to hedge your portfolio w...

Other stocks mentioned: BLNK, COCP, TTPH
Forbes - 7 months ago

We have some buying this morning with markets recovering some of Thursday’s massive losses. However, it looks uneasy at best.

Other stocks mentioned: COCP, INSE, KMPH
Seeking Alpha - 7 months ago

electroCore: Promising Product Means New Management Team Can Complete Unlikely Turnaround

Seeking Alpha - 8 months ago

electroCore, Inc. (ECOR) CEO Dan Goldberger on Q1 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

electroCore, Inc. (ECOR) delivered earnings and revenue surprises of -4.00% and 0.55%, respectively, for the quarter ended March 2020.

GlobeNewsWire - 8 months ago

Generated first quarter revenue of $734,000

Seeking Alpha - 9 months ago

Daily Insider Ratings Round Up 4/16/20

Other stocks mentioned: EHI, OPK, PHD, RHP, SPWR, SRC, JPM, PIH
GlobeNewsWire - 9 months ago

BASKING RIDGE, N.J., April 17, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today provided a business update, and introduced ...

GlobeNewsWire - 9 months ago

ITP program reimbursing for gammaCore™ extended to Sept. 30, 2020 ITP program reimbursing for gammaCore™ extended to Sept. 30, 2020

Benzinga - 9 months ago

ElectroCore, Inc (NASDAQ: ECOR) shares are trading higher on Friday, after the company announced it has submitted an emergency use authorization application to the FDA to allow the study and u...

Zacks Investment Research - 9 months ago

Top Ranked Momentum Stocks to Buy for April 3rd

Other stocks mentioned: AYTU, CTMX, DHT
GlobeNewsWire - 9 months ago

BASKING RIDGE, N.J., April 02, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that the company has submitted an...

Zacks Investment Research - 9 months ago

Top Ranked Momentum Stocks to Buy for March 31st

Other stocks mentioned: EURN, GO, SFM
GlobeNewsWire - 9 months ago

Approval makes novel non-invasive vagus nerve stimulation therapy available for prevention as well as acute treatment of migraines in adults Approval makes novel non-invasive vagus nerve stimu...

GlobeNewsWire - 9 months ago

BASKING RIDGE, N.J., March 27, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today announced that it has entered into a common...

GlobeNewsWire - 10 months ago

John Gandolfo, Tom Patton and Peter Cuneo to join the Board, adding significant medical technology operational, financial and turn-around experience John Gandolfo, Tom Patton and Peter Cuneo t...

About ECOR

electroCore, a commercial stage medical device company, engages in the development and commercialization of a range of patient administered non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld delivery system for multi-year use prescribed on a monthly basis. The company was founded in 2005 and is hea... [Read more...]

Industry
Medical Instruments & Supplies
IPO Date
Jun 22, 2018
CEO
Daniel S. Goldberger
Employees
51
Stock Exchange
NASDAQ
Ticker Symbol
ECOR
Full Company Profile

Financial Performance

In 2019, electroCore's revenue was $2.39 million, an increase of 140.72% compared to the previous year's $992,953. Losses were -$45.15 million, -19.12% less than in 2018.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for electroCore stock is "Buy." The 12-month stock price forecast is 3.50, which is an increase of 14.75% from the latest price.

Price Target
$3.50
(14.75% upside)
Analyst Consensus: Buy